Merck

EINDHOVEN, 06-Dec-2018 — /EuropaWire/ — Sponsh, an Eindhoven University of Technology spin-off that develops a temperature-sensitive textile which produces water from the air, has been voted the best chemical start-up of 2018. It is the third consecutive year that a TU/e … Read the full press release →

Closing of sale to Procter & Gamble at a cash purchase price of € 3.4 billion completed Successful completion allows Merck to further focus on innovation driven businesses in Healthcare, Life Science and Performance Materials Transaction successfully closed within an ambitious timeframe … Read the full press release →

Merck today (12 NOV 2018) signed an agreement with the Guangzhou Development District on innovation development in Southern China. DARMSTADT, Germany / GUANGZHOU, China, 14-Nov-2018 — /EuropaWire/ — Merck, the vibrant science and technology company, today signed an agreement with the … Read the full press release →

Lynparza met primary endpoint of progression-free survival in women with BRCA-mutated advanced ovarian cancer and showed a safety profile consistent with previous trials AstraZeneca and MSD’s Lynparza is the only PARP inhibitor to demonstrate significant activity in the 1st-line maintenance … Read the full press release →

Merck today (23 APR 2018) announced that the Chinese Patent Office has issued a notice granting Merck’s patent application for the company’s CRISPR technology used in a genomic-integration method for eukaryotic cells. Patent in China covers integration of an external … Read the full press release →

Lundbeck will make an upfront payment of EUR 100 million and the deal terms also include up to EUR 805 million in development, regulatory and sales milestones Foliglurax is a first-in-class treatment which entered clinical phase II testing in Parkinson’s … Read the full press release →

First Health Canada approved treatment for rare and aggressive type of skin cancer MISSISSAUGA, ON, 26-Feb-2018 — /EuropaWire/ — Merck, which operates as EMD Serono in the US and Canada, and Pfizer Canada Inc. announced that Health Canada has approved BAVENCIO™ … Read the full press release →

Toepfer joins from Metro Group, where he served as Head of the IT service company Metro Systems DARMSTADT, 26-Jan-2018 — /EuropaWire/ — Merck, a leading science and technology company, today announced that Dirk Toepfer will join the Group as the new … Read the full press release →

Lynparza is the first PARP inhibitor approved in Japan Lynparza tablets approved as maintenance treatment for women with platinum-sensitive relapsed ovarian cancer regardless of BRCA mutation status CAMBRIDGE, 22-Jan-2018 — /EuropaWire/ — AstraZeneca and Merck & Co., Inc., Kenilworth, NJ, … Read the full press release →